ZW2485A1 - Cloning of dna for protozoal antigens - Google Patents

Cloning of dna for protozoal antigens

Info

Publication number
ZW2485A1
ZW2485A1 ZW24/85A ZW2485A ZW2485A1 ZW 2485 A1 ZW2485 A1 ZW 2485A1 ZW 24/85 A ZW24/85 A ZW 24/85A ZW 2485 A ZW2485 A ZW 2485A ZW 2485 A1 ZW2485 A1 ZW 2485A1
Authority
ZW
Zimbabwe
Prior art keywords
cloning
dna
protozoal antigens
protozoal
antigens
Prior art date
Application number
ZW24/85A
Other languages
English (en)
Inventor
Arthur Holder Anthony
Singh Sandhu Jasbir
Gerrit Odink Karel
James Lockyer Michael
Riveros-Moreno Valentina
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848404692A external-priority patent/GB8404692D0/en
Priority claimed from GB848424340A external-priority patent/GB8424340D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of ZW2485A1 publication Critical patent/ZW2485A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZW24/85A 1984-02-22 1985-02-21 Cloning of dna for protozoal antigens ZW2485A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848404692A GB8404692D0 (en) 1984-02-22 1984-02-22 Cloning of dna for protozoal antigens
GB848424340A GB8424340D0 (en) 1984-09-26 1984-09-26 Cloning of dna

Publications (1)

Publication Number Publication Date
ZW2485A1 true ZW2485A1 (en) 1986-09-24

Family

ID=26287348

Family Applications (1)

Application Number Title Priority Date Filing Date
ZW24/85A ZW2485A1 (en) 1984-02-22 1985-02-21 Cloning of dna for protozoal antigens

Country Status (14)

Country Link
US (1) US5597708A (da)
EP (1) EP0154454B1 (da)
JP (2) JP2584733B2 (da)
AT (1) ATE64957T1 (da)
AU (1) AU592749B2 (da)
CA (1) CA1340103C (da)
DE (1) DE3583347D1 (da)
DK (1) DK79985A (da)
GB (1) GB2154592A (da)
HU (1) HU200794B (da)
IL (1) IL74409A (da)
NZ (1) NZ211191A (da)
PH (1) PH25993A (da)
ZW (1) ZW2485A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0153188B1 (en) * 1984-02-21 1991-10-09 National Research Development Corporation Improvements in or relating to the production of malaria vaccines
IL76338A (en) * 1984-09-11 1994-08-26 Saramane Pty Ltd Plasmodium plasmodium immunogenic polypeptides, AND molecules encoding them, a method for preparing the polypeptides and preparations containing the polypeptide
ZW8386A1 (en) * 1985-04-11 1986-07-23 Inst Medical W & E Hall Highly repetitive antigens of plasmodium falciparum
US4978621A (en) * 1985-09-03 1990-12-18 Scripps Clinic And Research Foundation Merozoite surface antigens
EP0252098A4 (en) * 1985-12-24 1989-11-29 Inst Medical W & E Hall ANTIGENS IN THE ASEXUAL BLOOD PHASE OF -i (PLASMODIUM FALCIPARUM).
EP0252588A3 (en) * 1986-05-12 1989-07-12 Smithkline Beecham Corporation Process for the isolation and purification of p. falciparum cs protein expressed in recombinant e. coli, and its use as a vaccine
US5001225A (en) * 1986-12-08 1991-03-19 Georgetown University Monoclonal antibodies to a pan-malarial antigen
GB8706599D0 (en) * 1987-03-19 1987-04-23 Hoffmann La Roche Plasmodium falciparum merozoite antigen peptides
DE3737238A1 (de) * 1987-11-03 1989-05-18 Behringwerke Ag Rekombinantes histidinreiches protein (37 kd antigen) von plasmodium falciparum, seine herstellung und verwendung
AT388934B (de) * 1987-11-13 1989-09-25 Wellcome Found Rekombinationskonjugatprotein und neue vakzinen
DE3831351A1 (de) * 1987-12-30 1989-07-13 Behringwerke Ag Malaria-spezifische dna-sequenzen, ihre expressionsprodukte und deren verwendung
US6333406B1 (en) 1988-08-12 2001-12-25 Joseph W. Inselburg Gene encoding protein antigens of Plasmodium falciparum and uses therefor
US5756101A (en) * 1991-07-01 1998-05-26 Pasteur Merieux Serums Et Vaccins Malaria recombinant poxvirus
US6855316B1 (en) * 1994-02-14 2005-02-15 University Of Hawaii Baculovirus produced Plasmodium falciparum vaccine
FR2744723A1 (fr) * 1996-02-14 1997-08-14 Pasteur Institut Proteine recombinante contenant un fragment c-terminal d'une proteine msp-1 d'un plasmodium infectieux pour l'homme pour la production de vaccins anti-paludiques
FR2744724B1 (fr) * 1996-02-14 2002-08-02 Pasteur Institut Proteine recombinante contenant un fragment c-terminal de la proteine msp-1 d'un plasmodium infectieux pour l'homme pour la production de vaccins anti-paludiques
DE19640817A1 (de) * 1996-10-02 1998-05-14 Hermann Prof Dr Bujard Rekombinantes Herstellungsverfahren für ein vollständiges Malaria-Antigen gp190/MSP 1
MY140679A (en) 2001-05-24 2010-01-15 Avanir Pharmaceuticals Inhibitors of macrohage migration inhibitory factor and methods for identifying the same
US20040082048A1 (en) * 2002-10-15 2004-04-29 Viswanath Nittala Venkata Narasimha Genes and protein sequences useful as drug targets for therapeutic action against protozoa
TW200418829A (en) * 2003-02-14 2004-10-01 Avanir Pharmaceutics Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
MXJL06000006A (es) 2003-08-22 2006-05-04 Avanir Pharmaceuticals Derivados de naftiridina sustituidos como inhibidores del factor inhibidor de la migracion de macrofagos y su uso en el tratamiento de enfermedades en el hombre.
JP2008534502A (ja) 2005-03-24 2008-08-28 アバニール・ファーマシューティカルズ マクロファージ遊走阻止因子の阻害剤としてのチエノピリジノン誘導体
GB0605689D0 (en) * 2006-03-21 2006-05-03 Novartis Ag Organic compounds
US7931908B2 (en) * 2007-02-23 2011-04-26 Philadelphia Health Education Corporation Chimeric MSP-based malaria vaccine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4466917A (en) * 1981-02-12 1984-08-21 New York University Malaria vaccine
GB2145092B (en) * 1983-01-28 1988-04-07 Univ New York Protective peptide antigen
IL65496A (en) * 1981-04-15 1985-10-31 Wellcome Found Protozoal antigen,its preparation and vaccine containing it
AU569722B2 (en) * 1983-01-28 1988-02-18 Saramane Pty Ltd Expression of plasmodium falciparum polypeptides from cloned cdna
US4767622A (en) * 1983-08-19 1988-08-30 University Of Illinois Method and materials for development of immunological responses protective against malarial infection
GB8404378D0 (en) * 1984-02-20 1984-03-28 Biogen Nv Dna sequence recombinant dna molecules

Also Published As

Publication number Publication date
GB2154592A (en) 1985-09-11
US5597708A (en) 1997-01-28
AU592749B2 (en) 1990-01-25
JPS6119490A (ja) 1986-01-28
PH25993A (en) 1992-01-13
JP2584733B2 (ja) 1997-02-26
JPH06189772A (ja) 1994-07-12
DE3583347D1 (de) 1991-08-08
HUT37460A (en) 1985-12-28
GB8504429D0 (en) 1985-03-27
AU3904685A (en) 1985-09-05
EP0154454B1 (en) 1991-07-03
HU200794B (en) 1990-08-28
ATE64957T1 (de) 1991-07-15
IL74409A0 (en) 1985-05-31
DK79985D0 (da) 1985-02-21
NZ211191A (en) 1988-01-08
DK79985A (da) 1985-08-23
EP0154454A1 (en) 1985-09-11
IL74409A (en) 1994-08-26
CA1340103C (en) 1998-10-27
JP2893626B2 (ja) 1999-05-24

Similar Documents

Publication Publication Date Title
IL74409A0 (en) Cloning of dna for protozoal antigens
DE3760912D1 (en) Retrovirus of the type hiv-2 capable of inducing aids, and the antigenic and nucleic acid components thereof
ZA853081B (en) Vaccine against rabies and process for preparation thereof
ZA851305B (en) Dna sequences,recombinant dna molecules and processes for producing late schizont-merozoite stage specific antigens of the human malarial parasite plasmodium falciparum
ZA886273B (en) Novel hiv proteins and peptides useful in the diagnosis,prophylaxis or therapy of aids
PT84850A (en) Process for isolating and purifying p.falciparum cs protein vaccine expressed in recombinant e.coli
EP0273800A3 (en) Hirudine variants, their use and preparation
ZA884486B (en) Promoters for the expression of foreign dna in methylotrophic bacteria,the obtaining thereof and the use thereof
EP0363436A4 (en) CLONED GENES OF PROTEIN G VERSIONS AND PROTEIN G VERSIONS EXPRESSED THEREOF.
ES2087092T3 (es) Procedimiento para la expresion de poligalacturonidasa y pectinesterasa en aspergillus niger y aspergillus awamori.
IL81026A0 (en) Peptides for immunizing against plasmodium falciparum,dna molecules coding for them and compositions containing said peptides
IL85759A0 (en) The cloning of malaria-specific dna sequences,isolation of the gene for the 140 kd protein
EP0217877A4 (en) VERY REPEATABLE ANTIGENS FROM PLASMODIUM FALCIPARUM.
DE3671603D1 (de) Verfahren zur zucht von babesia canis, verwendung zur herstellung von antigenen und impfstoffen und antigene und impfstoffe gegen piroplasmose.
ZA902436B (en) Purification of c.pseudotuberculosis toxin,and cloning and expression of toxin gene
IL85545A (en) 8-(4(-(2-pyrimidinyl)-1-piperazinyl)-but-2-inyl(or 2-enyl))-8-aza-spiro(4.5)decane-7-9-diones,process for their preparation and their use as intermediates in the preparation of anxioselective compounds
GB2199830B (en) Recombinant plasmid dna pvn22, coding for biosynthesis of human leukocyte interferon -i1 and strain pseudomonas sp. 31 (pvn22)
EP0322712A3 (en) Dna sequences specific for malaria, their expression products and applications thereof
ATE61818T1 (de) Dns-sequenzen, rekombinante dns und verfahren zur herstellung von plasmodium-falciparumantigenen.
IT8622272A0 (it) Metodo per l'identificazione immediata da colture di salmonella e preparazione del reattivo impiegato.
Gines Cloning and expression of the Aspergillus Oryzae o-Amylase gene.
Gharavi Molecular cloning of the human lipoxygenase gene
ATE84315T1 (de) Rekombinante dna zur reprimierbaren und induzierbaren expression von fremdgenen.
IE871212L (en) "process for isolating and purifying p. falciparum cs¹protein vaccine expressed in recombinant e. colt"
IT8619078A0 (it) Procedimento di trattamento speciale per prodotti in sughero.